249 related articles for article (PubMed ID: 10550664)
21. Recombinant fowlpox viruses expressing the glycoprotein B homolog and the pp38 gene of Marek's disease virus.
Yanagida N; Ogawa R; Li Y; Lee LF; Nazerian K
J Virol; 1992 Mar; 66(3):1402-8. PubMed ID: 1310754
[TBL] [Abstract][Full Text] [Related]
22. Interferon-containing supernatants increase Marek's disease herpesvirus genomes and gene transcription levels, but not virion replication in vitro.
Levy AM; Burgess SC; Davidson I; Underwood G; Leitner G; Heller ED
Viral Immunol; 2003; 16(4):501-9. PubMed ID: 14733737
[TBL] [Abstract][Full Text] [Related]
23. The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus.
Lee LF; Wu P; Sui D; Ren D; Kamil J; Kung HJ; Witter RL
Proc Natl Acad Sci U S A; 2000 May; 97(11):6091-6. PubMed ID: 10823954
[TBL] [Abstract][Full Text] [Related]
24. Marek's disease virus gene clones encoding virus-specific phosphorylated polypeptides and serological characterization of fusion proteins.
Cui ZZ; Yan D; Lee LF
Virus Genes; 1990 Apr; 3(4):309-22. PubMed ID: 1693456
[TBL] [Abstract][Full Text] [Related]
25. Transactivation of the Rous sarcoma virus long terminal repeat promoter by Marek's disease virus.
Tieber VL; Zalinskis LL; Silva RF; Finkelstein A; Coussens PM
Virology; 1990 Dec; 179(2):719-27. PubMed ID: 2173259
[TBL] [Abstract][Full Text] [Related]
26. Transactivation of latent Marek's disease herpesvirus genes in QT35, a quail fibroblast cell line, by herpesvirus of turkeys.
Yamaguchi T; Kaplan SL; Wakenell P; Schat KA
J Virol; 2000 Nov; 74(21):10176-86. PubMed ID: 11024146
[TBL] [Abstract][Full Text] [Related]
27. Expression of Marek's disease virus phosphorylated polypeptide pp38 produces splice variants and enhances metabolic activity.
Li X; Jarosinski KW; Schat KA
Vet Microbiol; 2006 Oct; 117(2-4):154-68. PubMed ID: 16876339
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a very virulent Marek's disease virus mutant expressing the pp38 protein from the serotype 1 vaccine strain CVI988/Rispens.
Lee LF; Cui X; Cui Z; Gimeno I; Lupiani B; Reddy SM
Virus Genes; 2005 Aug; 31(1):73-80. PubMed ID: 15965611
[TBL] [Abstract][Full Text] [Related]
29. Targeted Editing of the
Zhang Y; Luo J; Tang N; Teng M; Reddy VRAP; Moffat K; Shen Z; Nair V; Yao Y
Viruses; 2019 Apr; 11(5):. PubMed ID: 31027375
[TBL] [Abstract][Full Text] [Related]
30. Use of recombinant pp38 antigen of Marek's disease virus to identify serotype 1-specific antibodies in chicken sera by western blotting.
Li D; Green PF; Skinner MA; Jiang C; Ross N
J Virol Methods; 1994 Dec; 50(1-3):185-95. PubMed ID: 7714041
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of Marek's disease virus serotype 1 (MDV1) ICP22 gene product: MDV1 ICP22 transactivates the MDV1 ICP27 promoter synergistically with MDV1 ICP4.
Kato K; Izumiya Y; Tohya Y; Takahashi E; Hirai K; Kawaguchi Y
Vet Microbiol; 2002 Apr; 85(4):305-13. PubMed ID: 11856580
[TBL] [Abstract][Full Text] [Related]
32. Sequence determination of cDNA clones of transcripts from the tumor-associated region of the Marek's disease virus genome.
Iwata A; Ueda S; Ishihama A; Hirai K
Virology; 1992 Apr; 187(2):805-8. PubMed ID: 1312278
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of oncogenic and nononcogenic strains of Marek's disease virus type 1 by using polymerase chain reaction DNA amplification.
Zhu GS; Ojima T; Hironaka T; Ihara T; Mizukoshi N; Kato A; Ueda S; Hirai K
Avian Dis; 1992; 36(3):637-45. PubMed ID: 1329711
[TBL] [Abstract][Full Text] [Related]
34. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.
Goins WF; Sternberg LR; Croen KD; Krause PR; Hendricks RL; Fink DJ; Straus SE; Levine M; Glorioso JC
J Virol; 1994 Apr; 68(4):2239-52. PubMed ID: 8139009
[TBL] [Abstract][Full Text] [Related]
35. Interactions between Marek's disease virus encoded or induced factors and the Rous sarcoma virus long terminal repeat promoter.
Banders UT; Coussens PM
Virology; 1994 Feb; 199(1):1-10. PubMed ID: 8116231
[TBL] [Abstract][Full Text] [Related]
36. The genetic organization and transcriptional analysis of the short unique region in the genome of nononcogenic Marek's disease virus serotype 2.
Jang HK; Ono M; Kim TJ; Izumiya Y; Damiani AM; Matsumura T; Niikura M; Kai C; Mikami T
Virus Res; 1998 Nov; 58(1-2):137-47. PubMed ID: 9879770
[TBL] [Abstract][Full Text] [Related]
37. Nucleotide sequence of the glycoprotein C (gC) homologous gene of Marek's disease virus (MDV) serotype 2 and comparison of gC homologous genes among three serotypes of MDV.
Kitazawa T; Ono M; Maeda K; Kawaguchi Y; Kamiya N; Niikura M; Mikami T
J Vet Med Sci; 1993 Dec; 55(6):985-90. PubMed ID: 8117828
[TBL] [Abstract][Full Text] [Related]
38. The genome of a very virulent Marek's disease virus.
Tulman ER; Afonso CL; Lu Z; Zsak L; Rock DL; Kutish GF
J Virol; 2000 Sep; 74(17):7980-8. PubMed ID: 10933706
[TBL] [Abstract][Full Text] [Related]
39. Characterization of reticuloendotheliosis virus-transformed avian T-lymphoblastoid cell lines infected with Marek's disease virus.
Pratt WD; Morgan RW; Schat KA
J Virol; 1992 Dec; 66(12):7239-44. PubMed ID: 1279200
[TBL] [Abstract][Full Text] [Related]
40. Identification of a potential Marek's disease virus serotype 2 glycoprotein D gene with homology to herpes simplex virus glycoprotein D.
Jang HK; Ono M; Kato Y; Tohya Y; Niikura M; Mikami T
Arch Virol; 1996; 141(11):2207-16. PubMed ID: 8973534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
